Objective: Accessible, high-quality online health information is essential for patient under standing, particularly in specialized fields such as pediatric neurology. However, little is known about the readability and quality of Turkish-language online resources in this area. To evaluate the readability and quality of Turkish online educational materials on pediatric neurology using validated readability formulas and standardized quality assessment criteria. Materials and Methods: An Internet-based Patient Educational Material search was con ducted using Google with the terms “çocuk nöroloji” /''child neurology'' and “pediatrik nöroloji”/''pediatric neurology''. After applying exclusion criteria, 69 websites were included. These websites were categorized into 2 groups: Group 1 (academic and hospital websites) and Group 2 (physician and general health information websites). Readability was assessed using the Ateşman and Bezirci-Yılmaz formulas, while website quality was evaluated using the Journal of the American Medical Association (JAMA) benchmark criteria. Results: The median Ateşman Readability Score was 36.63, and the Bezirci-Yılmaz score was 7.04, indicating difficult readability. Only 13.04% of websites met ≥3 JAMA criteria and were classified as high quality. Group 2 (physician and general health information websites) had significantly higher quality scores than Group 1 (academic and hospital websites) (P < .001). No significant differences were found between groups in terms of readability. Conclusion: Most Turkish-language pediatric neurology websites are difficult to read and of low quality. Quality was higher in non-academic sources, although readability remained inadequate across all sources. These findings underscore the need for developing readable and high-quality online educational materials in pediatric neurology to enhance public under standing and informed health decisions.
Childhood epilepsy is one of the most common neurological disorders worldwide, significantly affecting cognitive, emotional, and social development. As car
Objective: Diffuse leptomeningeal glioneuronal tumor (DLGNT), including primary diffuse leptomeningeal oligodendroglial tumors (PDLOs) and leptomeningeal spread of high-grade gliomas, are rare pediatric neoplasms with diffuse leptomeningeal dissemination and limited parenchymal involvement. Their often nonspecific neurological symptoms frequently lead to misdiagnosis as infectious or inflammatory meningitis, complicating early identification. Methods: To investigate these diagnostic challenges, the authors retrospectively reviewed the records of 4 pediatric patients (2-13 years) diagnosed with leptomeningeal glial tumors over a 5-year period. Clinical features, neuroimaging, cerebrospinal fluid (CSF) findings, histopathology, treatment, and outcomes were analyzed. Results: All patients had subacute or chronic neurological symptoms, including gait ataxia (4/4), motor weakness (3/4), headache or vomiting (3/4), cognitive or behavioral decline (3/4), and seizures (2/4). Cerebrospinal fluid abnormalities contributed to diagnostic confusion but were not identical across all cases: pleocytosis was present in all patients, elevated protein was documented in those with available protein measurements, and reduced or relatively low glucose was observed only in some patients. Magnetic resonance imaging (MRI) demonstrated diffuse leptomeningeal involvement along the neuraxis in all patients, with cystic/nodular T2-hyperintense lesions and variable enhancement. Three patients were diagnosed within the DLGNT/PDLO spectrum and 1 with high-grade glioma with leptomeningeal dissemination. Hydrocephalus requiring ventriculoperitoneal shunting developed in 3/4 patients. All received chemotherapy; 1 required decompressive spinal surgery and craniospinal radiotherapy. At last follow-up, 3 patients were alive with neurological sequelae and 1 had died of progressive disease. Conclusion: These findings highlight that pediatric leptomeningeal glial tumors are diagnostically challenging and easily mistaken for chronic meningitis. Characteristic MRI findings, elevated CSF protein, and spinal dissemination are important clues.